Taoiseach Enda Kenny on stage at Inspirefest 2016. Image: Conor McCabe Photography
Envetec has secured €10m in financing for its technology addressing the issue of treating biohazardous waste safely and sustainably.
Former Taoiseach Enda Kenny is one of five new directors joining the board of Irish clean-tech company Envetec.
Based in Shannonside Business Park, Co Tipperary, Envetec was founded in 2021 as a spin-out from Technopath Clinical Diagnostics.
It has developed biohazardous waste treatment technology called Generations.
Designed to help laboratories phase out unsustainable methods of disposing of biohazardous waste, such as incineration, autoclaving and landfills, Generations simultaneously shreds and disinfects infectious waste and materials directly at the source, which can then be recycled.
Instead of using heat, the system uses a proprietary biodegradable chemical developed by Envetec that converts biohazardous waste into a confetti-like material that is safe to handle and transport for recycling.
“Our Generations technology is fast emerging as a significant disruptor, transforming the way in which we treat biohazardous laboratory waste,” said Malcolm Bell, CEO and chair of Envetec.
Kenny’s appointment to the Envetec board comes as the company has completed €10m in financing for the commercial launch of Generations after a decade of research and development.
New board members
Kenny, who led the Irish Government from 2011 to 2017, is one of five new independent, non-executive directors joining the Envetec board.
Others new members include Northwell Health CEO and president Michael Dowling, former Roche Diagnostics senior VP Eva Pisa, former S&P Global Market Intelligence president Imogen Joss (who is now chair of Grant Thornton UK), and My Green Lab CEO James Connelly.
“We have identified five outstanding independent directors who have the right mix of leadership skills and experience underscored by a genuine, collective passion for advancing best-in-class technologies that benefit the environment and the economy,” Bell said.
“With these new additions to the board, Envetec is strongly positioned across the diagnostic, pharmaceutical, medical device, and food and beverage industries with an opportunity to impact the environmental footprint of the customers we serve.”
Kenny has been adding climate-focused companies to his directorship portfolio.
Last September, he joined the board of Dublin-based climate-tech company Carbon Collect, which recently unveiled its first commercial-scale ‘mechanical tree’ designed to capture CO2 from the atmosphere.
10 things you need to know direct to your inbox every weekday. Sign up for the Daily Brief, Silicon Republic’s digest of essential sci-tech news.
